GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | December 18, 2024 |
PDB ID | UniProt ID | Title | Descriptor |
---|---|---|---|
7MIY | Q00975 | Human N-type voltage-gated calcium channel Cav2.2 at 3.1 Angstrom resolution | |
7MIY | P54284 | Human N-type voltage-gated calcium channel Cav2.2 at 3.1 Angstrom resolution | |
7MIY | P54289 | Human N-type voltage-gated calcium channel Cav2.2 at 3.1 Angstrom resolution | |
7MJK | P0DTC2 | Cryo-EM structure of the SARS-CoV-2 N501Y mutant spike protein ectodomain bound to Fab ab1 (class 2) | |
7MJK | 7MJK | Cryo-EM structure of the SARS-CoV-2 N501Y mutant spike protein ectodomain bound to Fab ab1 (class 2) | |
7MQ6 | A0A778V697 | Tetragonal Maltose Binding Protein in the presence of gold | |
7MTZ | Q6JC40 | Structure of the adeno-associated virus 9 capsid at pH pH 7.4 in complex with terminal galactose | |
7MWW | A0A2I6PIY1 | Structure of hepatitis C virus envelope full-length glycoprotein 2 (eE2) from J6 genotype | |
7MWW | 7MWW | Structure of hepatitis C virus envelope full-length glycoprotein 2 (eE2) from J6 genotype | |
7N0H | P0DTC2 | CryoEM structure of SARS-CoV-2 spike protein (S-6P, 2-up) in complex with sybodies (Sb45) | |
7N0H | 7N0H | CryoEM structure of SARS-CoV-2 spike protein (S-6P, 2-up) in complex with sybodies (Sb45) | |
7N0U | P15494 | Complex of recombinant Bet v 1 with Fab fragment of REGN5713 | |
7N0U | 7N0U | Complex of recombinant Bet v 1 with Fab fragment of REGN5713 | |
7N19 | P01903 | DR3 in complex with Aspergillus nidulans NAD-dependent histone deacetylase hst4 peptide | |
7N19 | Q5Y7D1 | DR3 in complex with Aspergillus nidulans NAD-dependent histone deacetylase hst4 peptide | |
7N19 | 7N19 | DR3 in complex with Aspergillus nidulans NAD-dependent histone deacetylase hst4 peptide | |
7N1Q | P0DTC2 | Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants | |
7N1T | P0DTC2 | Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants | |
7N1U | P0DTC2 | Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants | |
7N1V | P0DTC2 | Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants | |
7N1W | P0DTC2 | Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants | |
7N1X | P0DTC2 | Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants | |
7N1Y | P0DTC2 | Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants | |
7N3I | P0DTC2 | Crystal structure of the SARS-CoV-2 receptor binding domain in complex with the human neutralizing antibody Fab fragment C098 | |
7N3I | 7N3I | Crystal structure of the SARS-CoV-2 receptor binding domain in complex with the human neutralizing antibody Fab fragment C098 | |
7N4U | Q9UHC9 | Structure of human NPC1L1 | |
7N4V | Q9UHC9 | Structure of cholesterol-bound human NPC1L1 | |
7N4X | Q9UHC9 | Structure of human NPC1L1 mutant-W347R | |
7N62 | P0DTC2 | SARS-CoV-2 Spike (2P) in complex with C12C9 Fab (NTD local reconstruction) | |
7N62 | 7N62 | SARS-CoV-2 Spike (2P) in complex with C12C9 Fab (NTD local reconstruction) | |
7N64 | P0DTC2 | SARS-CoV-2 Spike (2P) in complex with G32R7 Fab (RBD and NTD local reconstruction) | |
7N64 | 7N64 | SARS-CoV-2 Spike (2P) in complex with G32R7 Fab (RBD and NTD local reconstruction) | |
7N65 | A0A6H1VCM1 | Complex structure of HIV superinfection Fab QA013.2 and BG505.SOSIP.664 | |
7N65 | Q2N0S7 | Complex structure of HIV superinfection Fab QA013.2 and BG505.SOSIP.664 | |
7N65 | 7N65 | Complex structure of HIV superinfection Fab QA013.2 and BG505.SOSIP.664 | |
7N86 | Q9BYE9 | Crystal Structure of Human Protocadherin-24 EC1-2 Form II | |
7N8H | P0DTC2 | SARS-CoV-2 S (B.1.429 / epsilon variant) + S2M11 + S2L20 Global Refinement | |
7N8H | 7N8H | SARS-CoV-2 S (B.1.429 / epsilon variant) + S2M11 + S2L20 Global Refinement | |
7N8I | P0DTC2 | SARS-CoV-2 S (B.1.429 / epsilon variant) + S2M11 + S2L20 (Local Refinement of the NTD/S2L20) | |
7N8I | 7N8I | SARS-CoV-2 S (B.1.429 / epsilon variant) + S2M11 + S2L20 (Local Refinement of the NTD/S2L20) | |
7NCX | G2Q1N4 | Crystal structure of GH30 (double mutant EE) from Thermothelomyces thermophila. | |
7ND3 | P0DTC2 | EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-40 Fab | |
7ND3 | 7ND3 | EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-40 Fab | |
7ND4 | P0DTC2 | EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-88 Fab | |
7ND4 | 7ND4 | EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-88 Fab | |
7ND5 | P0DTC2 | EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-150 Fab | |
7ND5 | 7ND5 | EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-150 Fab | |
7ND6 | P0DTC2 | EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-40 Fab | |
7ND6 | 7ND6 | EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-40 Fab | |
7ND7 | P0DTC2 | EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-316 Fab |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024